Clinical trial
Efficacy and Safety Study of Dapagliflozin in Type 1 Diabetes
The purpose of this study is to determine if adding dapagliflozin to insulin is a safe and effective therapy to improve glycemic control in patients with type 1 diabetes.
| Category | Value |
|---|---|
| Study start date | 2014-10-15 |